Skip to main content

Can a supercomputer save us from the coronavirus? We spoke to the man who knows

Across the world, dozens of research labs and hundreds of researchers are busy actively investigating possible vaccines for the coronavirus, officially known as COVID-19. At the U.S. Department of Energy’s Oak Ridge National Laboratory, researchers have recently started using Summit, the world’s most powerful supercomputer, to try and discover drug compounds that might be able to stop the coronavirus from infecting host cells.

In only two days, the work by the IBM-built supercomputer has yielded the discovery of 77 small-molecule drug compounds with the potential to battle COVID-19. It does this by running advanced simulations, as opposed to the traditional “wet lab” approach to drug discovery, which would take years to reach the same point. Not only can Summit help quickly discover possible proteins, it can rank the compounds in order of their potential value for further experimentation. On today’s Digital Trends Live, we spoke to one of the brains behind IBM’s superpowered artificial brain.

Related Videos

“[This compound discovery work is done] by virtue of writing software that’s based on an understanding of chemistry, physics, and so on,” Dave Turek, vice president of technical computing at IBM Cognitive Systems, told Digital Trends. “That allows them to simulate the behavior of the virus in the presence of a healthy cell. You move away from [the] concept of biology that you think of from your high school days of beakers and pipettes and things like that, to doing everything computationally in a digital world. By virtue of doing that, you can actually explore the science of the virus and potential therapeutic agents much much faster than you could in a … classic kind of laboratory setting.”

To be clear, Summit’s discovery doesn’t mean that a cure or treatment for the current coronavirus pandemic has been discovered. However, these findings can be used as the basis for future studies, as well as provide a framework that traditional wet labs can use to investigate the new compounds. It will be possible to find out if any of them are capable of killing the virus as hoped.

Right now, the number one target for vaccines is, of course, the current coronavirus. But research such as this can be more broadly applicable too. The use of A.I. to discover more effective and lower-cost drugs will, in the coming years, lead to breakthroughs in the way that all manner of diseases and conditions are treated.

A paper describing the Oak Ridge National Laboratory research was recently published in the journal ChemRxiv.

Editors' Recommendations

Can chloroquine cure coronavirus? Here’s what science says
France Toughens Coronavirus Lockdown As Death Toll Rises

The U.S. Food and Drug Administration (FDA) made a controversial decision in March when it authorized the drugs chloroquine and hydroxychloroquine to be added to the Strategic National Stockpile, allowing doctors to prescribe them to patients with COVID-19, commonly known as the coronavirus. The move came a week after President Donald Trump tweeted an endorsement of the drugs, saying they "have a real chance to be one of the biggest game changers in the history of medicine.”

Read more
Your next Apple Store visit will be unlike any you have made before
The Apple Store in Zurich

Apple’s head of retail has explained to customers how it plans to open its brick-and-mortar stores following their closure in March due to the coronavirus pandemic.

In a letter posted on its website on Sunday, May 17, Deirdre O’Brien, the tech company’s senior vice president of retail and people, detailed new procedures for its more than 500 sites globally that will be in place for the foreseeable future.

Read more
Trump administration wants to bring chip manufacturing to the U.S.
Huawei Kirin 980 processor

The U.S. government is hoping to persuade chip manufacturers Intel and TSMC (Taiwan Semiconductor Manufacturing Co.) to build factories in the U.S., according to a report by the Wall Street Journal.

The Trump administration is reportedly concerned about relying on overseas manufacturers, especially those in Asia, for a supply of all-important processors. Driven by the coronavirus pandemic, which has wreaked havoc on global supply chains in all industries including computing, the U.S. is seeking to secure a supply of essential components manufactured within its own borders.

Read more